Recently, a storm caused by the centralized medical procurement policy has caused huge waves in the medical field in the mainland. As some of the original drugs were forced to withdraw from the domestic market, many netizens publicly expressed their dissatisfaction. Centralized medical procurement is a new policy aimed at reducing the price of drugs through centralized procurement, but at the same time, a series of new problems and controversies have emerged. In the face of such a grim situation, how should we view this incident and find a rational and reasonable way out?
The reason for the incident is simple. Medical centralized procurement directly reduces the price of drugs through large-scale centralized procurement, which seems to benefit ordinary patients, but it also makes it difficult for some original drugs to compete and is forced to end. This has brought great inconvenience to patients who rely on the original drug, and has also ignited dissatisfaction among netizens. The topic of "small pharmacies support the original drug" spread rapidly, and everyone said that the original drug is still better than the generic drug in terms of safety and therapeutic effect, so they resolutely do not choose the latter.
People's concerns are very normal. The medical industry is closely related to people's health and life safety, and no policy can ignore quality issues. Although centralized medical procurement can theoretically reduce costs and increase efficiency, if it is difficult to ensure the quality and continuity of drugs in the implementation process, the consequences will be difficult to predict. The mentality of netizens' opposition actually shows the inevitable omissions in the implementation of the policy.
But at the same time, the original intention of medical centralized procurement cannot be denied. Medical resources are limited, and ways to reduce drug prices are worth studying. The analysis shows that the centralized medical procurement itself should not become the object of criticism, and the key is to improve the relevant system so that the interests of all parties can be balanced to the greatest extent.
Netizens are hotly discussed
Netizens said: There is nothing wrong with centralized procurement, and the medical insurance that does not enter the centralized procurement will not be reimbursed, who wants to use it at their own expense, why don't you let it be used?
Netizens said: India's generic drugs have passed the FDA standards of Europe and the United States and can be sold in the European and American markets, and we also require our generic drug companies to meet the same standards!
Netizens said: Obviously, the efficacy can't keep up, and the research and development can't keep up, so I have to say that the price is advantageous... If it can't cure the disease, what's the use of being cheaper?
Netizens said: These guys don't take the health of the people to heart at all, so they want to know if these guys don't use the original medicine?
Netizens said: In fact, what everyone wants to express is that the hospital provides sufficient collection of medicines, as well as imported medicines, and everyone can choose freely according to their own circumstances.
The research shows that the mechanism of medical centralized procurement can be improved from the following aspects
1. Strengthen the supervision of the quality of generic drugs. Clarify the audit criteria to ensure that its quality can be compared with the original drug. This will dispel the unease of the masses.
2. Re-evaluate the rationality of medical centralized procurement. We should not only pursue the price, but also see the effect and the demand for medication. It is necessary to combine different patient types and give a more flexible policy space.
3. Launch solutions for innovator drugs. For example, encourage R&D investment, increase the proportion of domestic high-quality original drugs, and let more drugs have the opportunity to stay in the market competition.
4. Strengthen medical information services. Understand the doubts of the masses in a timely manner, and carry out necessary explanations and guidance. At the same time, it is also necessary to collect feedback and continuously improve the implementation rules of medical centralized procurement.
5. Guide the public to understand the original intention of medical centralized procurement. The price reduction is convenient for the people, but it will never affect the quality and effect of the drug, and everyone should treat it with a rational and tolerant attitude.
Write at the end
In general, the original intention of the medical centralized procurement policy is positive, and the key is to do a good job in the overall planning and opening up of all links, so that all aspects can be coordinated and developed through continuous improvement. This incident is worth pondering: policy implementation requires multiple thinking, and we must not ignore any detail foreshadowing. Only by comprehensively demonstrating the problem, finding a realistic way out, and releasing the positive energy of the policy to the greatest extent can we truly benefit the health of the masses. Protecting the rights and interests of patients is the supreme guide of our medical practice.
What do you think about this matter? Welcome to leave a message in the comment area to discuss